Fibrinolytic study in a homozygous protein C deficient patient.

Abstract:

:The fibrinolytic system was evaluated in a patient with homozygous protein C deficiency as well as in several members of his family with a partial deficiency of this protein. Before anticoagulant therapy the patient showed skin lesions which quickly disappeared after administration of fresh plasma. After anticoagulant treatment, the propositus suffered two clinical episodes of "ecchymotic" lesions, which were controlled with fresh plasma. The patient has remained free of new lesions and other clinical episodes up to the present date. The fibrinolytic activity of both the propositus and his family was normal. The patient's father showed adequate release of tissue plasminogen activator after controlled physical exercise. According to clinical and analytical data from our patient and his family, it is suggested that, in spite of the preservation of the fibrinolytic system in this case, a localized deficiency in fibrinolysis could exist in view of the clinical behaviour of the skin lesions described.

journal_name

Thromb Res

journal_title

Thrombosis research

authors

Aznar J,Dasi A,España F,Estellés A

doi

10.1016/0049-3848(86)90260-4

subject

Has Abstract

pub_date

1986-05-01 00:00:00

pages

313-22

issue

3

eissn

0049-3848

issn

1879-2472

journal_volume

42

pub_type

杂志文章
  • Antiphospholipid antibodies in children without and in adults with and without thrombophilia.

    abstract::Antiphospholipid antibodies (APAs) are considered risk factors in patients with thromboembolic diseases. Although the incidence of such acquired coagulation disturbances in adults are well described, only few data exist for children. Therefore, in a first step to collect new data we analyzed the presence of different ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/s0049-3848(99)00241-8

    authors: Siemens HJ,Gutsche S,Brückner S,Bucsky P,Katus HA

    更新日期:2000-05-15 00:00:00

  • Prevalence and risk factors of atherothrombotic events among 1054 hemophilia patients: a population-based analysis.

    abstract:INTRODUCTION:Reports on the prevalence and risk factors of atherothrombotic events (AEs) are conflicting in persons with hemophilia (PWH). METHODS:This study evaluated the prevalence and risk factors of AEs among 1054 male hemophilia patients, using data collected from Taiwan's National Health Insurance Research Datab...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2014.12.027

    authors: Wang JD,Chan WC,Fu YC,Tong KM,Chang ST,Hwang WL,Lin CH,Tsan YT

    更新日期:2015-03-01 00:00:00

  • Allele frequencies of two polymorphisms associated with the factor IX gene in Iranian population.

    abstract::Indirect genetic diagnosis using polymorphic DNA markers can be useful in large-scale screening programs, which is technically simpler, more rapid and amenable. The main objective of this study was to test the informativeness of two common intragenic markers (TaqI and XmnI) in Iranian haemophilia B families to detect ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2004.03.009

    authors: Ghandil P,Ghadiri A,Farhud D,Zeinali S

    更新日期:2004-01-01 00:00:00

  • Low molecular weight heparin (KABI 2165, Fragmin): pharmacokinetics after intravenous and subcutaneous administration in human volunteers.

    abstract::The pharmacokinetics of a low molecular weight heparin (LMWH) with a mean mw of 4000-6000 D (KABI 2165, Fragmin) was studied in 6 healthy volunteers after intravenous (iv) and subcutaneous (sc) administration of 120 U (anti FXa)/kg. The half-life in plasma of the anti FXa activity after iv injection was 119 +/- 17 min...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(86)90340-3

    authors: Bratt G,Törnebohm E,Widlund L,Lockner D

    更新日期:1986-06-01 00:00:00

  • VTE prophylaxis for the medical patient: where do we stand? - a focus on cancer patients.

    abstract::Acutely ill medical patients are at moderate to high risk of venous thromboembolism (VTE): approximately 10-30% of general medical patients may develop deep-vein thrombosis or pulmonary embolism, and the latter is a leading contributor to deaths in hospital. Medical conditions associated with a high risk of VTE includ...

    journal_title:Thrombosis research

    pub_type: 杂志文章,评审

    doi:10.1016/S0049-3848(10)70008-6

    authors: Cohen AT,Nandini B,Wills JO,Ota S

    更新日期:2010-04-01 00:00:00

  • What's next after the clot? Residual pulmonary vascular obstruction after pulmonary embolism: From imaging finding to clinical consequences.

    abstract::Surviving an embolism exposes patients to potential long-term complications, such as altered quality of life, persistent dyspnea, impaired exercise capacity or pulmonary hypertension. The common objective factor in most of these situations is the presence of residual pulmonary vascular obstruction (RPVO). Planar venti...

    journal_title:Thrombosis research

    pub_type: 杂志文章,评审

    doi:10.1016/j.thromres.2019.09.038

    authors: Bonnefoy PB,Margelidon-Cozzolino V,Catella-Chatron J,Ayoub E,Guichard JB,Murgier M,Bertoletti L

    更新日期:2019-12-01 00:00:00

  • Prevention of severe bleeding by tranexamic acid in a patient with disseminated intravascular coagulation.

    abstract::Severe bleeding took place in a patient when abdominal aneurysm was removed by operation. Bleeding continued after infusion of heparin, antithrombin III (ATIII), fresh platelets and fresh blood. Infusion of tranexamic acid resulted in an immediate cessation of bleeding and improvement of his general condition. Sometim...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(90)90167-b

    authors: Takada A,Takada Y,Mori T,Sakaguchi S

    更新日期:1990-04-15 00:00:00

  • Inhibitory effects of TFPI on thrombin and factor Xa generation in vitro--modulatory action of glycosaminoglycans.

    abstract::The effect of tissue factor pathway inhibitor (TFPI) on thrombin and factor Xa generation was studied in an in vitro system using a prothrombin complex concentrate. It was found that TFPI, via the direct inhibition of factor Xa and the tissue factor/factor VIIa complex, inhibited both the further generation of factor ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(94)90173-2

    authors: Kaiser B,Hoppensteadt DA,Jeske W,Wun TC,Fareed J

    更新日期:1994-09-15 00:00:00

  • Anti- and procoagulant activities in factor VII-deficient subjects.

    abstract::The clinical feature in patients with congenital factor VII deficiency is in part dependent on the underlying genetic defect, but the mechanisms influencing the genotype-phenotype correlation remain to be fully elucidated. In addition, thromboembolic events have been reported. Compensatory mechanisms involving vitamin...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/s0049-3848(00)00410-2

    authors: Astermark J,Tengborn L,Hedner U,Berntorp E

    更新日期:2001-03-15 00:00:00

  • Secondary stroke prevention with low-dose aspirin, sustained release dipyridamole alone and in combination. ESPS Investigators. European Stroke Prevention Study.

    abstract::Patients who had survived a stroke or transient ischaemic attacks (TIA) were admitted to a trial of low-dose aspirin (50 mg) alone, sustained release dipyridamole (400 mg/day) alone, or a combination of the two agents, and results compared with a placebo over 24 months. This low-dose aspirin regimen produced in pairwi...

    journal_title:Thrombosis research

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/s0049-3848(98)00099-1

    authors: Forbes CD

    更新日期:1998-09-15 00:00:00

  • PO-01 - Congestive heart failure is an independent risk factor for venous thromboembolism and mortality in cancer patients.

    abstract:INTRODUCTION:Prediction of venous thromboembolism (VTE) occurrence in cancer patients using individual risk factors may contribute to preventing the burden of disease associated with VTE. Congestive heart failure in patients with cancer may increase the risk of VTE and worsen the prognosis. AIM:We sought to investigat...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/S0049-3848(16)30134-7

    authors: Königsbrügge O,Riedl J,Grilz E,Wiltschke C,Zielinski C,Pabinger I,Ay C

    更新日期:2016-04-01 00:00:00

  • Dietary pectin influences fibrin network structure in hypercholesterolaemic subjects.

    abstract::Fibrinogen is an important risk factor for atherosclerosis, stroke and cardiovascular heart disease (CHD). This risk is increased when associated with a high serum cholesterol. Furthermore, it is also believed that not only fibrinogen concentration, but also the quality of fibrin networks may be an important risk fact...

    journal_title:Thrombosis research

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/s0049-3848(97)00062-5

    authors: Veldman FJ,Nair CH,Vorster HH,Vermaak WJ,Jerling JC,Oosthuizen W,Venter CS

    更新日期:1997-05-01 00:00:00

  • Circulating platelet-leukocyte aggregates: a marker of microvascular injury in diabetic patients.

    abstract::Diabetes is associated with multiple disorders including metabolic, cellular and blood disturbances leading to vascular complications. Increased circulating levels of platelet-leukocyte aggregates (PLA) have been described in several thrombotic diseases. In this study, we have evaluated circulating PLA in diabetic pat...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2007.07.016

    authors: Elalamy I,Chakroun T,Gerotziafas GT,Petropoulou A,Robert F,Karroum A,Elgrably F,Samama MM,Hatmi M

    更新日期:2008-01-01 00:00:00

  • Apixaban for the prevention of venous thromboembolism in high-risk ambulatory cancer patients receiving chemotherapy: Rational and design of the AVERT trial.

    abstract::Patients with active cancer have a heightened risk of venous thromboembolism (VTE). This risk is further increased by the initiation of chemotherapy. Although previous studies have suggested that the use of parenteral thromboprophylaxis in all ambulatory cancer patients receiving chemotherapy significantly decreases t...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2018.01.018

    authors: Kimpton M,Wells PS,Carrier M

    更新日期:2018-04-01 00:00:00

  • ABO blood group is associated with peripheral arterial disease in African Americans: The Multi-Ethnic Study of Atherosclerosis (MESA).

    abstract:INTRODUCTION:Peripheral artery disease (PAD) affects 8.5 million Americans and thus improving our understanding of PAD is critical to developing strategies to reduce disease burden. The objective of the study was to determine the association of ABO blood type with ankle brachial index (ABI) as well as prevalent and inc...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2017.02.018

    authors: Pike MM,Larson NB,Wassel CL,Cohoon KP,Tsai MY,Pankow JS,Hanson NQ,Decker PA,Berardi C,Alexander KS,Cushman M,Zakai NA,Bielinski SJ

    更新日期:2017-05-01 00:00:00

  • Comparison of the effects of streptokinase, t-PA and APSAC on human platelet aggregation in vitro in the absence and presence of aspirin.

    abstract::SK, t-PA or APSAC were incubated in human plasma (adjusted to 300,000 platelets/mm3), in vitro, for up to 90 minutes using concentrations which were equivalent to those achieved in the treatment of AMI patients. Aggregation was measured in response to ADP and collagen. SK inhibited platelet aggregation after a 60 minu...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(90)90105-l

    authors: Fears R,Ferres H,Greenwood HC

    更新日期:1990-11-15 00:00:00

  • Impact of atrial fibrillation/flutter on the in-hospital mortality of surgical patients - Results from the German nationwide cohort.

    abstract:BACKGROUND:To investigate the impact of atrial fibrillation/flutter (AF) on adverse in-hospital outcomes in hospitalized surgical patients. METHODS:The nationwide German inpatient sample of the years 2005-2018 was used for this analysis. Surgical patients were stratified by AF and compared. Logistic regression models ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2020.10.015

    authors: Keller K,Hobohm L,Engelhardt M

    更新日期:2020-12-01 00:00:00

  • Influence of alpha- and beta-adrenoceptors on thrombin-induced serotonin release in rat platelets.

    abstract::This work was designed to investigate the influence of rat platelet adrenoceptors on the early thrombin-induced serotonin release. In washed platelets prelabeled with [3H]-serotonin, adrenaline and isoproterenol both inhibited, in a dose-dependent manner, the early thrombin-induced secretion of serotonin. Inhibitory r...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(85)90325-1

    authors: Koutouzov S,Cothenet-Vernoux L,Marche P,Dausse JP

    更新日期:1985-10-15 00:00:00

  • PO-33 - Heparin suppresses progression of small cell lung cancer (SCLC) in an orthotopic mouse model.

    abstract:INTRODUCTION:Lung cancer is the leading cause of cancer-related death worldwide. Small cell lung cancer (SCLC) is thereby a highly aggressive neuroendocrine carcinoma representing about 15% of all lung cancer cases. Due to the highly metastatic behavior and multidrug resistance, the long-term survival of patients is ve...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/S0049-3848(16)30166-9

    authors: Taromi S,Catusse J,Elverfeldt DV,Reichardt W,Ledig B,Zeiser R,Burger M

    更新日期:2016-04-01 00:00:00

  • Symptomatic and asymptomatic deep vein thrombosis after total hip replacement. Differences in phlebographic pattern, described by a scoring of the thrombotic burden.

    abstract::The aim was to describe the phlebographic pattern of asymptomatic and symptomatic deep vein thrombosis (DVT) after total hip replacement by the use of a scoring system in 102 consecutive patients (54 asymptomatic, 48 symptomatic). The DVTs were scored from 1 to 3, and registered in a scoring system dividing the deep v...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/s0049-3848(00)00274-7

    authors: Björgell O,Nilsson PE,Benoni G,Bergqvist D

    更新日期:2000-09-01 00:00:00

  • Ultrastructure and composition of thrombi in coronary and peripheral artery disease: correlations with clinical and laboratory findings.

    abstract:INTRODUCTION:Fibrin structure and cellular composition of thrombi profoundly affect the clinical outcomes in ischemic coronary and peripheral artery disease. Our study addressed the interrelations of structural features of thrombi and routinely measured laboratory parameters. MATERIALS AND METHODS:Thrombi removed by t...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2015.02.004

    authors: Kovács A,Sótonyi P,Nagy AI,Tenekedjiev K,Wohner N,Komorowicz E,Kovács E,Nikolova N,Szabó L,Kovalszky I,Machovich R,Szelid Z,Becker D,Merkely B,Kolev K

    更新日期:2015-04-01 00:00:00

  • Glycerophospholipid metabolism: back to the future.

    abstract::It has become customary to regard the various glycerophospholipids as quite similar, and the acyl groups are considered to have little influence on the behaviour of the lipids in membranes or metabolism. Nevertheless, a number of recent observations by the authors and others indicate a high degree of metabolic compart...

    journal_title:Thrombosis research

    pub_type: 杂志文章,评审

    doi:10.1016/0049-3848(92)90006-v

    authors: Holmsen H,Hindenes JO,Fukami M

    更新日期:1992-08-01 00:00:00

  • Functional characterization of a novel missense mutation, His147Arg, in A1 domain of FV protein causing type II deficiency.

    abstract:INTRODUCTION:Congenital factor V (FV) deficiency is a rare inherited disorder. Three compound heterozygous missense mutations, Asp68His, His147Arg, and Arg2074Cys, were observed in a Taiwanese patient with moderately severe FV deficiency. METHOD:The novel His147Arg mutation in the A1 domain was investigated by protein...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2014.04.005

    authors: Liu HC,Lin TM,Eng HL,Lin YT,Shen MC

    更新日期:2014-07-01 00:00:00

  • Activation of human prothrombin by the venom of Lonomia achelous (Cramer) caterpillars.

    abstract::In this paper, we demonstrated that the procoagulant action of Lonomia achelous (Cramer) is due in part to a component that activates prothrombin. The activation by crude venom and Fractions obtained by gel filtration on Sephadex G-75 is not dependent of phospholipid, Ca++ or Factor V. The activation of prothrombin by...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(92)90187-f

    authors: Guerrero B,Arocha-Piñango CL

    更新日期:1992-05-01 00:00:00

  • Antithrombotic actions of selective inhibitors of blood coagulation factor Xa in rat models of thrombosis.

    abstract::The antithrombotic actions of selective factor Xa (FXa) inhibitors, recombinant tick anticoagulant peptide (rTAP) and DX-9065a, were evaluated in experimental thrombosis models in anesthetized rats. In the first model, thrombosis was induced by exposing flowing blood to a silk thread anchored in an arteriovenous (AV) ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(96)00112-0

    authors: Wong PC,Crain EJ Jr,Nguan O,Watson CA,Racanelli A

    更新日期:1996-07-15 00:00:00

  • Effect of warfarin on intracranial hemorrhage incidence and fatal outcomes.

    abstract:INTRODUCTION:Avoiding intracranial hemorrhage (ICH) during warfarin therapy is critical but little is known about factors that affect warfarin-related ICH outcomes. We aimed to define the impact of warfarin on ICH incidence rates and to identify baseline clinical characteristics of patients who experienced ICH and fact...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2013.10.024

    authors: Witt DM,Delate T,Hylek EM,Clark NP,Crowther MA,Dentali F,Ageno W,Martinez KD,Garcia DA

    更新日期:2013-01-01 00:00:00

  • Thromboembolism and anticoagulant management in hemodialysis patients: a practical guide to clinical management.

    abstract::The need for anticoagulation in dialysis patients is common and the incidence of venous thromboembolism (VTE) and atrial fibrillation in this population is high. While direct data are lacking on the management of anticoagulation in dialysis patients, careful weighing of risks and benefits on the basis of evidence from...

    journal_title:Thrombosis research

    pub_type: 杂志文章,实务指引

    doi:10.1016/j.thromres.2005.03.031

    authors: Lo DS,Rabbat CG,Clase CM

    更新日期:2006-01-01 00:00:00

  • A human factor VIIa concentrate and its effects in the hemophilic A dog.

    abstract::Properties of a new concentrate of FVII/FVIIa, obtained by adsorption onto an inorganic adsorbent followed by a chromatographic step onto Q-Sepharose using a by-product of routine fractionation as starting material, are described. This fraction contains only small amounts of the other components of the prothrombin com...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(89)90126-6

    authors: Chabbat J,Hampikian-Lenin S,Toully V,Gaillandre A,Péjaudier L,Steinbuch M

    更新日期:1989-06-15 00:00:00

  • Detection of hypofibrinolysis in stable coronary artery disease using the overall haemostatic potential assay.

    abstract:INTRODUCTION:Patients with stable coronary artery disease (CAD) are at risk of arterial thrombosis causing myocardial infarction. Detection of global haemostatic markers of hypercoagulability and hypofibrinolysis may be important for risk stratification and individualised treatment. We examined overall haemostatic pote...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2013.03.015

    authors: Reddel CJ,Curnow JL,Voitl J,Rosenov A,Pennings GJ,Morel-Kopp MC,Brieger DB

    更新日期:2013-05-01 00:00:00

  • Low endogenous thrombin potential in trained subjects.

    abstract:INTRODUCTION:A paradox seems to exist: exercising leads to clotting activation in conventional clotting tests, but exercising persons have a low risk of thrombosis. In this study we tried to evaluate the effect of exercise performance status on in vitro plasma thrombin generation, which represents an overall function t...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2013.04.009

    authors: Cimenti C,Schlagenhauf A,Leschnik B,Schretter M,Tschakert G,Gröschl W,Seibert FJ,Hofmann P,Muntean WE

    更新日期:2013-06-01 00:00:00